Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer

Molecular Biology Reports

Volumn 39, Issue 1, 2012, Pages 661-668

  Piao, Daxun ^a   Jiang, Tao ^a   Liu, Gavin ^b   Wang, Baosheng ^b   Xu, Jin ^b   Zhu, Anlong ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

ALCAM; Breast cancer; Immunohistochemical staining and western blot; Metastasis; Survival

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM VESICLE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MOLECULAR PATHOLOGY; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENT CANCER; TUMOR LOCALIZATION; TUMOR VOLUME;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; BLOTTING, WESTERN; BREAST NEOPLASMS; CHINA; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN;

EID: 84855192802     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0783-5     Document Type: Article

References (18)

1. RS Rampaul SE Pinder CW Elston IO Ellis Nottingham Breast Team 2001 Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team Eur J Surg Oncol 27 229 238 11373098 10.1053/ejso.2001.1114 1:STN:280:DC%2BD3M3ptVWmsA%3D%3D (Pubitemid 32621745)
2. DF Hayes C Isaacs V Stearns 2001 Prognostic factors in breast cancer: current and new predictors of metastasis J Mammary Gland Biol Neoplasia 6 375 392 12013528 10.1023/A:1014778713034 1:STN:280:DC%2BD383ntVGmtQ%3D%3D (Pubitemid 39600496)
3. KS Kimbro K Duschene M Willard JA Moore S Freeman 2008 A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment Mol Biol Rep 35 23 27 17415682 10.1007/s11033-006-9047-1 1:CAS:528:DC%2BD1cXhtFahurw%3D
4. WG Degen LC van Kempen EG Gijzen JJ van Groningen Y van Kooyk HP Bloemers GW Swart 1998 MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines is identical to ALCAM (activated leukocyte cell adhesion molecule) Am J Pathol 152 805 813 9502422 1:CAS:528:DyaK1cXitFent7k%3D (Pubitemid 28110727)
5. MA Bowen AA Aruffo J Bajorath 2000 Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions Proteins 40 420 428 10861932 10.1002/1097-0134(20000815)40:3<420::AID-PROT70>3.0.CO;2-U 1:CAS:528:DC%2BD3cXlsFCrtb8%3D (Pubitemid 30624449)
6. JP Stephan L Bald PE Roberts J Lee Q Gu JP Mather 1999 Distribution and function of the adhesion molecule BEN during rat development Dev Biol 212 264 277 10433820 10.1006/dbio.1999.9348 1:CAS:528:DyaK1MXkvVOkuro%3D (Pubitemid 29387935)
7. B Seshi S Kumar D Sellers 2000 Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages Blood Cells Mol Dis 26 234 246 10950944 10.1006/bcmd.2000.0301 1:CAS:528: DC%2BD3cXlslCqtbk%3D
8. GW Swart PC Lunter JW Kilsdonk LC Kempen 2005 Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration? Cancer Metastasis Rev 24 223 236 15986133 10.1007/s10555-005-1573-0 1:CAS:528:DC%2BD2MXls1agsLc%3D (Pubitemid 40922796)
9. K Tomita A van Bokhoven CF Jansen MJ Bussemakers JA Schalken 2000 Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin Biochem Biophys Res Commun 267 870 874 10673383 10.1006/bbrc.1999.2040 1:CAS:528:DC%2BD3cXhtVKmsb0%3D (Pubitemid 30099415)
10. Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, Loening S, Dietel M, Rosenthal A (2003) ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 54:34-43 (Pubitemid 36043834)
11. Burkhardt M, Mayordomo E, Winzer KJ, Fritzsche F, Gansukh T, Pahl S, Weichert W, Denkert C, Guski H, Dietel M, Kristiansen G (2006) Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol 59:403-409
12. King JA, Ofori-Acquah SF, Stevens T, Al-Mehdi AB, Fodstad O, Jiang WG (2004) Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 6:R478-R487
13. Al-Rawi MA, Rmali K, Watkins G, Mansel RE, Jiang WG (2004) Aberrant expression of interleukin-7 (IL-7) and its signaling complex in human breast cancer. Eur J Cancer 40:494-502 (Pubitemid 38220764)
14. K Larsen PM Frandsen LB Madsen C Bendixen 2010 Molecular cloning, characterization and developmental expression of porcine beta-synuclein Mol Biol Rep 37 1439 1449 19343535 10.1007/s11033-009-9531-5 1:CAS:528: DC%2BC3cXhtlWqu78%3D
15. AM Bamberger C Methner BW Lisboa C Städtler HM Schulte T Löning K Milde-Langosch 1999 Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype Int J Cancer 84 533 538 10502734 10.1002/(SICI)1097- 0215(19991022)84:5<533::AID-IJC16>3.0.CO;2-J 1:CAS:528:DyaK1MXmslGhsLc%3D
16. M Ihnen V Müller RM Wirtz C Schröder S Krenkel I Witzel BW Lisboa F Jänicke K Milde-Langosch 2008 Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer Breast Cancer Res Treat 112 419 427 18172759 10.1007/s10549-007-9879-y 1:CAS:528: DC%2BD1cXhtl2mu7nP
17. S Choi M Kobayashi J Wang H Habelhah F Okada J Hamada T Moriuchi Y Totsuka M Hosokawa 2000 Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin Clin Exp Metastasis 18 45 50 11206837 10.1023/A:1026507713080 1:CAS:528:DC%2BD3MXhtVaqtb8%3D (Pubitemid 32096048)
18. PC Lunter JW van Kilsdonk H van Beek IM Cornelissen M Bergers PH Willems GN van Muijen GW Swart 2005 Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity Cancer Res 65 8801 8808 16204050 10.1158/0008-5472. CAN-05-0378 1:CAS:528:DC%2BD2MXhtVKiu7zN (Pubitemid 41377368)